Delivery Order SPE2DB20D3101-SPE2DB24FRCK3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,933.98 delivery order contract is for the supply of the pharmaceutical product Junel FE 1 mg-20 mcg tablets in quantities of 28. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,105.40 firm fixed-price delivery order is for the supply of the medication Junel FE 1.5 mg-30 mcg tablets. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,055.78 firm fixed-price delivery order is for the supply of 4,555,517,703 units of the pharmaceutical product Junel FE 1 mg-20 mcg tablet, a prescription medication. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Junel FE 1 mg-20 mcg tablets. The $1,333.70 firm fixed-price contract has a performance period ending on March 15, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,104.48, is for the delivery of the pharmaceutical product Junel FE 1 mg-20 mcg tablet in packages of 28. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1.5 mg-30 mcg tablets. The contract, valued at $2,452.14, is a firm fixed-price delivery order that was awarded on March 25, 2022 with a completion date of March 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- This federal contract award is for the delivery of Junel FE 1.5 mg-30 mcg tablets in quantities of 28, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,081.15 and was issued as a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. The $7,280.71 Firm Fixed Price Delivery Order has a completion date of September 7, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. The $6,393.17 firm fixed-price delivery order contract has an ultimate completion date of August 25, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Junel FE 1.5 mg-30 mcg tablets. The $4,237.45 firm-fixed-price contract has a period of performance through January 25, 2022. AmerisourceBergen, a subsidiary of Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRCK3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,401.92, is for the delivery of Junel FE 1 mg-20 mcg tablets in 28-count packages. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs. These contracting vehicles enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/28/24 |